Purification of a viral coat protein by an engineered polyionic sequence.

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy Vector Development

Background:

• Polyoma coat protein VP1 is a key component for artificial vector systems.
• Traditional purification methods yield low quantities of VP1 protein.
• VP1 protein aggregation can limit its utility in vector development.

Purpose of the Study:

• To develop an efficient purification strategy for polyoma coat protein VP1.
• To create a modified VP1 protein with improved solubility and assembly properties.
• To establish a functional artificial vector system for gene therapy applications.

Main Methods:

• Recombinant expression of VP1 in E. coli.
• Introduction of a polyionic tag (eight glutamic acid residues) into a surface-exposed loop of VP1.
• Purification using ammonium sulfate precipitation, anion-exchange chromatography, and size-exclusion chromatography.
• In vitro assembly studies to assess particle formation.

Main Results:

• A novel affinity purification procedure using a polyionic tag significantly improved VP1 yield and purity.
• The modified VP1 protein exhibited reduced aggregation compared to wild-type VP1.
• The mutant VP1 protein successfully assembled into homogeneous virus-like particles under conditions similar to wild-type assembly.

Conclusions:

• The developed affinity purification method is highly effective for producing pure VP1.
• The engineered VP1 mutant offers a promising building block for stable gene therapy vectors.
• This approach facilitates the development of advanced artificial vector systems for gene delivery.